Medartis Holding AG | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Medartis Holding AG

PRESS RELEASE

published on 08/20/2024 at 07:05, 3 months 1 day ago

Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
BRIEF

published on 07/09/2024 at 07:04, 4 months 12 days ago

Matthias Schupp Appointed as CEO of Medartis

Medical Technology CEO Appointment Medartis Matthias Schupp
PRESS RELEASE

published on 07/09/2024 at 06:59, 4 months 12 days ago

Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
Medartis appoints Matthias Schupp as CEO, succeeding Christoph Brönnimann. Schupp brings extensive experience in the medical technology sector

CEO Appointment Leadership Transition Medartis Matthias Schupp Medical Technology Sector
BRIEF

published on 06/11/2024 at 07:04, 5 months 10 days ago

Medartis Announces Resignation of CEO Christoph Brönnimann

Corporate Leadership CEO Resignation Business Transition Medartis Christoph Brönnimann
PRESS RELEASE

published on 06/11/2024 at 06:59, 5 months 10 days ago

Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Brönnimann
Medartis Holding AG announces resignation of CEO Christoph Brönnimann. The Board initiates search for successor to ensure smooth transition and future growth

Resignation CEO Successor Transition Medartis Holding AG
BRIEF

published on 04/04/2024 at 07:30, 7 months 17 days ago

Medartis Holding AG Successfully Places CHF 115.8 Million in Convertible Bonds

Convertible Bonds Financial Strategy Medartis Holding AG Orthopaedic Surgery Investor Base Expansion
PRESS RELEASE

published on 04/04/2024 at 07:25, 7 months 17 days ago

Medartis successfully places CHF 115.8 million convertible bonds due 2031
Medartis Holding AG successfully completes CHF 115.8 million convertible bond placement due 2031 for strategic business expansion and acquisitions. CFO Dirk Kirsten highlights growth opportunities

Convertible Bonds Business Expansion Medartis Holding AG Funding Purposes Dirk Kirsten
BRIEF

published on 04/03/2024 at 17:48, 7 months 17 days ago

Medartis Announces CHF 115 Million Convertible Bond Offering

Investment Growth Financial Strategy Medartis Holding AG Convertible Bond Offering Orthopaedic Surgery
PRESS RELEASE

published on 04/03/2024 at 17:43, 7 months 17 days ago

Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Medartis Holding AG launches a private placement offering of approximately CHF 115 million in senior convertible bonds due 2031, to be used for general financing and acquisitions. BofA Securities Europe SA and Zürcher Kantonalbank serve as Joint Bookrunners

Private Placement Offering Convertible Bonds Zürcher Kantonalbank Medartis Holding AG BofA Securities Europe SA
PRESS RELEASE

published on 03/12/2024 at 06:30, 8 months 9 days ago

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%

Accesswire

Published on 11/21/2024 at 13:30, 31 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 31 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 1 minute ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 46 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 26 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 46 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 55 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 1 minute ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 3 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 41 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 16 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 16 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE